EARNINGS
- Share via
* Merck & Co. said profit rose 19% in the third quarter to $1.84 billion, or 78 cents a share, beating expectations of 73 cents. Sales jumped 29% to $10.56 billion, led by strong sales of its Vioxx drug for arthritis and Zocor for high cholesterol.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
